Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
99 EUR | -1.39% | +1.38% | +0.16% |
Apr. 24 | CARL ZEISS MEDITEC AG : Gets a Buy rating from UBS | ZD |
Apr. 23 | CARL ZEISS MEDITEC AG : Receives a Sell rating from JP Morgan | ZD |
Sales 2024 * | 2.27B 2.43B | Sales 2025 * | 2.55B 2.74B | Capitalization | 8.85B 9.49B |
---|---|---|---|---|---|
Net income 2024 * | 258M 277M | Net income 2025 * | 326M 350M | EV / Sales 2024 * | 3.5 x |
Net cash position 2024 * | 920M 986M | Net cash position 2025 * | 361M 387M | EV / Sales 2025 * | 3.33 x |
P/E ratio 2024 * |
33.9
x | P/E ratio 2025 * |
26.7
x | Employees | 4,823 |
Yield 2024 * |
1.08% | Yield 2025 * |
1.24% | Free-Float | 40.86% |
Latest transcript on Carl Zeiss Meditec AG
1 day | -1.39% | ||
1 week | +1.38% | ||
Current month | -14.51% | ||
1 month | -16.17% | ||
3 months | +0.53% | ||
6 months | +31.33% | ||
Current year | +0.16% |
Managers | Title | Age | Since |
---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 21-12-30 |
Director of Finance/CFO | 59 | 18-09-30 | |
Christian Müller
BRD | Director/Board Member | 56 | 09-12-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kaschke
BRD | Director/Board Member | 66 | 01-12-31 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 21-05-26 |
Heike Madan
BRD | Director/Board Member | 52 | 23-03-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.71% | 202 M€ | -.--% | ||
0.52% | 2 M€ | +13.56% | - | |
0.49% | 79 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 99 | -1.39% | 82,762 |
24-04-24 | 100.4 | -2.14% | 178,345 |
24-04-23 | 102.6 | +4.06% | 192,660 |
24-04-22 | 98.6 | +0.92% | 130,657 |
24-04-19 | 97.7 | +0.05% | 137,446 |
Delayed Quote Xetra, April 25, 2024 at 11:36 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.16% | 9.6B | |
+7.71% | 220B | |
+6.25% | 185B | |
+10.60% | 133B | |
+26.73% | 107B | |
-0.57% | 62.91B | |
+15.42% | 53.34B | |
-1.89% | 47.71B | |
-1.91% | 40.29B | |
+11.16% | 39.57B |
- Stock Market
- Equities
- AFX Stock